Unregistered

I think they are referring to metastatic patients when they say they eventually relapse. I asked my oncologist this when I was first diagnosed as in "If being Her2+ is so great these days, why all the bad press" and he said that most of the time they are not referring to patients with early stage disease when they make these statements. This was over 2 years ago and I would guess that with even more drugs coming out for metastatic patients (neratinib, TDM-1), that diagnosis is changing as well.